张长青,李彦豪,庄建良,吴伟岗,潘群雄,陈勇.胆道内支架置入术治疗恶性梗阻性黄疸的疗效分析[J].中国医学影像技术,2001,17(6):559~561 |
胆道内支架置入术治疗恶性梗阻性黄疸的疗效分析 |
Therapeutic Effect Treatment on Malignant Obstructive Jaundice with Percutaneous Transhepatic Stent Implantation |
投稿时间:2000-10-28 |
DOI: |
中文关键词: 放射学,介入性 内支架 胆管阻塞 胆管肿瘤 |
英文关键词:Radiology, interventional Stent Biliary obstruction Biliary tumor |
基金项目: |
|
摘要点击次数: 1986 |
全文下载次数: 943 |
中文摘要: |
目的 探讨经皮肝胆道内支架置入治疗恶性梗阻性黄疸的疗效及并发症。方法 对32例恶性梗阻性黄疸患者经皮肝穿胆道内行支架置入术,其中28例为内涵管,4例为金属内支架。随访35~376天,观察近中期疗效和并发症。结果 经皮肝胆道内支架置入术技术成功率为100%。置入术后1周血总胆红素水平较置入前明显下降(P<0.001)。开通时间平均为101天,半年开通率为56.25%。并发症发生率24.98%,为主要包括胰腺炎和逆行胆道感染等。结论 经皮肝胆道内架置入术疗效可靠,是一种安全,可作为恶性胆管阻塞介入治疗的一种姑息性疗法。 |
英文摘要: |
Purpose To investigate the effect and complication of percutaneous transhepatic stent implantation. Methods Percutaneous transhepatic stent implantation was performed in 32 patients with malignant obstructive jaundice: plastic stent of 28 patients, metal stent of 4 patients. The early and late theraputic effects and complications of 32 patients were observed in 35-376 days follow up periods. Results Technical success rate was 100%. Serum total bilirubin decreased significantly after percutaneous transhepatic stent implantation in the first week (P<0.001). The mean patency time was 101 days,the ratio of half-year patency was 56.25%.The complications occurred in 24.98% of patients,mainly included pancreatitis and retrograde biliary infection. Conclusion Percutaneous transhepatic stent implantation is effective and safe, it can be used as a choice of interventional treatment to malignant biliary obstruction. |
查看全文 查看/发表评论 下载PDF阅读器 |
|
|
|